Pharmacogenomics of Methotrexate Pathway in Rheumatoid Arthritis Patients: Approach toward Personalized Medicine

Background: Methotrexate (MTX) is one of the most common medications used for rheumatoid arthritis (RA) treatment. Single-nucleotide polymorphisms (SNPs) could potentially predict variability in therapeutic outcomes. Aim: This study aims to assess the impact of SNPs in genes encoding for the MTX pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdallah, Hoda Y., Ibrahim, Maha E., Abd El-Fadeal, Noha M., Ali, Dina A., Elsehrawy, Gehad G., Badr, Rasha E., Hassoba, Howayda M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9325258/
https://www.ncbi.nlm.nih.gov/pubmed/35885466
http://dx.doi.org/10.3390/diagnostics12071560

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9325258/
https://www.ncbi.nlm.nih.gov/pubmed/35885466
http://dx.doi.org/10.3390/diagnostics12071560

Ejemplares similares